Quarterly report pursuant to Section 13 or 15(d)

Schedule of Unrecognized Compensation Expense (Details)

v3.22.2.2
Schedule of Unrecognized Compensation Expense (Details)
$ in Thousands
6 Months Ended
Jun. 30, 2022
USD ($)
PAVmed Inc 2014 Equity Plan [Member] | Stock Options [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Unrecognized Expense $ 9,127
Weighted Average Remaining Service Period 2 years 3 months 18 days
PAVmed Inc 2014 Equity Plan [Member] | Restricted Stock [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Unrecognized Expense $ 1,510
Weighted Average Remaining Service Period 1 year 2 months 12 days
Lucid Diagnostics Inc 2018 Equity Plan [Member] | Stock Options [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Unrecognized Expense $ 4,030
Weighted Average Remaining Service Period 2 years 7 months 6 days
Lucid Diagnostics Inc 2018 Equity Plan [Member] | Restricted Stock [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Unrecognized Expense $ 10,873
Weighted Average Remaining Service Period 1 year